Literature DB >> 16847689

Clinicopathologic characteristics of sporadic Japanese Creutzfeldt-Jakob disease classified according to prion protein gene polymorphism and prion protein type.

Yasushi Iwasaki1, Mari Yoshida, Yoshio Hashizume, Tetsuyuki Kitamoto, Gen Sobue.   

Abstract

We analyzed neuropathologic features of 23 Japanese patients with sporadic Creutzfeldt-Jakob disease (sCJD) by means of prion protein (PrP) immunolabeling associated with codon 129 polymorphism of the PrP gene and western blot analysis of protease-resistant PrP (PrP type). Clinical features, particularly age at onset, disease duration, periodic synchronous discharge and presence of myoclonus, were also analyzed. This study included 11 cases of subacute spongiform encephalopathy (SSE), 10 cases of panencephalopathic (PE)-type sCJD and two cases of thalamic-type sCJD, classified according to cerebral pathology findings. According to PrP gene polymorphism and PrP type, 18 cases were classified as MM1-type, two as MV1-type, two as MM2-type and one as MM1 + 2-type sCJD. SSE and PE-type sCJD showed similar clinical features, with the exception of disease duration, codon 129 polymorphism and PrP type. Thalamic-type sCJD showed different clinical features and PrP type. We suggest that SSE and PE-type sCJD comprise the sCJD subtype and that PE-type sCJD is a prolonged pathologic phenotype of SSE. When we compare our results with those from a series of Caucasian sCJD patients, the percentages of codon 129 polymorphisms differed, as did classification based on PrP gene polymorphism and PrP type; our series included many PE-type sCJD cases and disease duration was relatively long and MM2-type cases showed clinicopathologic variability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847689     DOI: 10.1007/s00401-006-0111-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  10 in total

1.  Gastrostomy in patients with prion disease.

Authors:  Yasushi Iwasaki; Keiko Mori; Masumi Ito; Yoshinari Kawai; Ken-Ichiro Hoshino; Yuko Kawabata; Maya Mimuro; Mari Yoshida
Journal:  Prion       Date:  2017-05-16       Impact factor: 3.931

2.  Pathological progression of genetic Creutzfeldt-Jakob disease with a PrP V180I mutation.

Authors:  Akio Akagi; Yasushi Iwasaki; Maya Mimuro; Tetsuyuki Kitamoto; Masahito Yamada; Mari Yoshida
Journal:  Prion       Date:  2018-01-31       Impact factor: 3.931

3.  Aquaporins and neurodegenerative diseases.

Authors:  Eleonora Foglio; Luigi Fabrizio Rodella
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

4.  White matter involvement in sporadic Creutzfeldt-Jakob disease.

Authors:  Eduardo Caverzasi; Maria Luisa Mandelli; Stephen J DeArmond; Christopher P Hess; Paolo Vitali; Nico Papinutto; Abby Oehler; Bruce L Miller; Irina V Lobach; Stefano Bastianello; Michael D Geschwind; Roland G Henry
Journal:  Brain       Date:  2014-11-02       Impact factor: 13.501

5.  Clinicopathological features of the rare form of Creutzfeldt-Jakob disease in R208H-V129V PRNP carrier.

Authors:  Dorina Tiple; Anna Poleggi; Vittorio Mellina; Antonino Morocutti; Livia Brusa; Cesare Iani; Elisa Colaizzo; Luana Vaianella; Simone Baiardi; Anna Ladogana; Piero Parchi; Maurizio Pocchiari
Journal:  Acta Neuropathol Commun       Date:  2019-03-21       Impact factor: 7.801

6.  Clinicopathological findings of an MM2-cortical-type sporadic Creutzfeldt-Jakob disease patient with cortical blindness during a course of glaucoma and age-related macular degeneration.

Authors:  Yuichi Hayashi; Yasushi Iwasaki; Masahiro Waza; Hideaki Shibata; Akio Akagi; Akio Kimura; Takashi Inuzuka; Katsuya Satoh; Tetsuyuki Kitamoto; Mari Yoshida; Takayoshi Shimohata
Journal:  Prion       Date:  2019-01       Impact factor: 3.931

7.  Specific clinical signs and symptoms are predictive of clinical course in sporadic Creutzfeldt-Jakob disease.

Authors:  E Nakatani; Y Kanatani; H Kaneda; Y Nagai; S Teramukai; T Nishimura; B Zhou; S Kojima; H Kono; M Fukushima; T Kitamoto; H Mizusawa
Journal:  Eur J Neurol       Date:  2016-05-24       Impact factor: 6.089

8.  Clinicopathological findings of a long-term survivor of V180I genetic Creutzfeldt-Jakob disease.

Authors:  Yuichi Hayashi; Yasushi Iwasaki; Masahiro Waza; Shinei Kato; Akio Akagi; Akio Kimura; Takashi Inuzuka; Katsuya Satoh; Tetsuyuki Kitamoto; Mari Yoshida; Takayoshi Shimohata
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

9.  Analysis of Chinese patients with sporadic Creutzfeldt-Jakob disease.

Authors:  Jing Yang; Haiyan Kuang; Qiong Wang; Jiao Liu; Xueping Chen; Huifang Shang
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

10.  System degeneration in an MM1-type sporadic Creutzfeldt-Jakob disease case with an unusually prolonged akinetic mutism state.

Authors:  Yasushi Iwasaki; Keiko Mori; Masumi Ito; Yoshinari Kawai; Akio Akagi; Yuichi Riku; Hiroaki Miyahara; Atsushi Kobayashi; Tetsuyuki Kitamoto; Mari Yoshida
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.